288 related articles for article (PubMed ID: 29384270)
41. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
El-Kasaby A; Kasture A; Koban F; Hotka M; Asjad HMM; Kubista H; Freissmuth M; Sucic S
Neuropharmacology; 2019 Dec; 161():107572. PubMed ID: 30885608
[TBL] [Abstract][Full Text] [Related]
42. [Elucidation of Disease Mechanisms Based on Transport Function at Tissue Barriers and Challenges in Drug Development].
Ito S
Yakugaku Zasshi; 2019; 139(4):497-503. PubMed ID: 30930376
[TBL] [Abstract][Full Text] [Related]
43. Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review.
Rostami P; Hosseinpour S; Ashrafi MR; Alizadeh H; Garshasbi M; Tavasoli AR
Acta Neurol Belg; 2020 Jun; 120(3):511-516. PubMed ID: 31222513
[TBL] [Abstract][Full Text] [Related]
44. X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model.
Levin MD; Bianconi S; Smith A; Cawley NX; Do AD; Hammond D; Grafstein JF; Thurm A; Miller J; Perreault J; Noguchi A; Springer D; Kozel BA; Spurney CF; Wassif CA; Yu ZX; Schulze A; Porter FD; Hannah-Shmouni F
Genet Med; 2021 Oct; 23(10):1864-1872. PubMed ID: 34050321
[TBL] [Abstract][Full Text] [Related]
45. Cerebral creatine deficiency: Black cat in the coal cellar.
Cherian A; Divya KP
Acta Neurol Belg; 2021 Dec; 121(6):1859-1861. PubMed ID: 32681499
[No Abstract] [Full Text] [Related]
46. Creatine Transporter Deficiency in Two Brothers with Autism Spectrum Disorder.
Aydin HI
Indian Pediatr; 2018 Jan; 55(1):67-68. PubMed ID: 29396939
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic variability in a portuguese family with x-linked creatine transport deficiency.
Garcia P; Rodrigues F; Valongo C; Salomons GS; Diogo L
Pediatr Neurol; 2012 Jan; 46(1):39-41. PubMed ID: 22196490
[TBL] [Abstract][Full Text] [Related]
48. [A family with creatine transporter deficiency diagnosed with urinary creatine/creatinine ratio and the family history: the third Japanese familial case].
Nozaki F; Kumada T; Shibata M; Fujii T; Wada T; Osaka H
No To Hattatsu; 2015 Jan; 47(1):49-52. PubMed ID: 25803912
[TBL] [Abstract][Full Text] [Related]
49. Distal Xq28 microdeletions: clarification of the spectrum of contiguous gene deletions involving ABCD1, BCAP31, and SLC6A8 with a new case and review of the literature.
Calhoun AR; Raymond GV
Am J Med Genet A; 2014 Oct; 164A(10):2613-7. PubMed ID: 25044748
[TBL] [Abstract][Full Text] [Related]
50. Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder.
Yıldız Y; Göçmen R; Yaramış A; Coşkun T; Haliloğlu G
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093139
[TBL] [Abstract][Full Text] [Related]
51. Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database.
Betsalel OT; Rosenberg EH; Almeida LS; Kleefstra T; Schwartz CE; Valayannopoulos V; Abdul-Rahman O; Poplawski N; Vilarinho L; Wolf P; den Dunnen JT; Jakobs C; Salomons GS
Eur J Hum Genet; 2011 Jan; 19(1):56-63. PubMed ID: 20717164
[TBL] [Abstract][Full Text] [Related]
52. Disorders of creatine transport and metabolism.
Longo N; Ardon O; Vanzo R; Schwartz E; Pasquali M
Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):72-8. PubMed ID: 21308988
[TBL] [Abstract][Full Text] [Related]
53. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
54. Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8.
Ferrada E; Wiedmer T; Wang WA; Frommelt F; Steurer B; Klimek C; Lindinger S; Osthushenrich T; Garofoli A; Brocchetti S; Bradberry S; Huang J; MacNamara A; Scarabottolo L; Ecker GF; Malarstig A; Superti-Furga G
J Mol Biol; 2024 Jan; 436(2):168383. PubMed ID: 38070861
[TBL] [Abstract][Full Text] [Related]
55. Creatine transporter knockout mice (Slc6a8) show increases in serotonin-related proteins and are resilient to learned helplessness.
Abdulla ZI; Pennington JL; Gutierrez A; Skelton MR
Behav Brain Res; 2020 Jan; 377():112254. PubMed ID: 31542396
[TBL] [Abstract][Full Text] [Related]
56. Creatine transporter defect diagnosed by proton NMR spectroscopy in males with intellectual disability.
Mencarelli MA; Tassini M; Pollazzon M; Vivi A; Calderisi M; Falco M; Fichera M; Monti L; Buoni S; Mari F; Engelke U; Wevers RA; Hayek J; Renieri A
Am J Med Genet A; 2011 Oct; 155A(10):2446-52. PubMed ID: 21910234
[TBL] [Abstract][Full Text] [Related]
57. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.
Stockler S; Schutz PW; Salomons GS
Subcell Biochem; 2007; 46():149-66. PubMed ID: 18652076
[TBL] [Abstract][Full Text] [Related]
58. X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease.
Mejdahl Nielsen M; Petersen ET; Fenger CD; Ørngreen MC; Siebner HR; Boer VO; Považan M; Lund A; Grønborg SW; Hammer TB
Mol Genet Metab; 2023 Nov; 140(3):107694. PubMed ID: 37708665
[TBL] [Abstract][Full Text] [Related]
59. A new case of creatine transporter deficiency associated with mild clinical phenotype and a novel mutation in the SLC6A8 gene.
Alcaide P; Rodriguez-Pombo P; Ruiz-Sala P; Ferrer I; Castro P; Ruiz Martin Y; Merinero B; Ugarte M
Dev Med Child Neurol; 2010 Feb; 52(2):215-7. PubMed ID: 20002129
[No Abstract] [Full Text] [Related]
60. Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Passi GR; Pandey S; Devi ARR; Konanki R; Jain AR; Bhatnagar S; Tripathi R; Jain V
Brain Dev; 2022 Apr; 44(4):271-280. PubMed ID: 34974949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]